Home » Topics » BioWorld Science

BioWorld Science
RSS

Arris announces preliminary results for APC-366

May 3, 1996

Rupatadine poised to enter phase II

May 3, 1996

Ibogaine development to be discussed at international meeting

May 3, 1996

TAK-218 discussed at length at Japanese meetings

May 3, 1996

Tanabe's T-477 shows neuroprotective effects

May 3, 1996

Jouveinal's neuroprotective sigma ligand JO-1994

May 3, 1996

RPR describes NMDA/glycine-site antagonists

May 3, 1996

Maxi-K channel modulators from Bayer

May 3, 1996

Berlex attempts to block approval of Avonex in U.S.

May 3, 1996

Pola describes dopamine reuptake inhibitors for Parkinson's disease

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...